Canada markets open in 8 hours 50 minutes

Esperion Therapeutics, Inc. (ESPR)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.0500+0.0575 (+5.79%)
At close: 04:00PM EDT
1.0400 -0.01 (-0.95%)
After hours: 07:52PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 112.34M
Enterprise Value 237.00M
Trailing P/E N/A
Forward P/E 0.60
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.98
Price/Book (mrq)74.89
Enterprise Value/Revenue 2.70
Enterprise Value/EBITDA -1.44

Trading Information

Stock Price History

Beta (5Y Monthly) 0.13
52-Week Change 3-85.64%
S&P500 52-Week Change 314.91%
52 Week High 38.8700
52 Week Low 30.8500
50-Day Moving Average 31.4590
200-Day Moving Average 32.9488

Share Statistics

Avg Vol (3 month) 33.41M
Avg Vol (10 day) 36.09M
Shares Outstanding 5106.99M
Implied Shares Outstanding 6106.99M
Float 886.08M
% Held by Insiders 10.51%
% Held by Institutions 185.75%
Shares Short (Aug 30, 2023) 415.18M
Short Ratio (Aug 30, 2023) 44.04
Short % of Float (Aug 30, 2023) 417.32%
Short % of Shares Outstanding (Aug 30, 2023) 414.19%
Shares Short (prior month Jul 30, 2023) 413.41M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Jun 29, 2023


Profit Margin -252.82%
Operating Margin (ttm)-193.14%

Management Effectiveness

Return on Assets (ttm)-39.41%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)87.91M
Revenue Per Share (ttm)1.07
Quarterly Revenue Growth (yoy)36.90%
Gross Profit (ttm)-70.42M
EBITDA -169.47M
Net Income Avi to Common (ttm)-222.26M
Diluted EPS (ttm)-2.7400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)138.47M
Total Cash Per Share (mrq)1.29
Total Debt (mrq)522.9M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.17
Book Value Per Share (mrq)-3.69

Cash Flow Statement

Operating Cash Flow (ttm)-164.41M
Levered Free Cash Flow (ttm)-130.88M